What is the recommended schedule for Hepatitis B (HBV) vaccination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Hepatitis B Vaccination Schedule

The recommended schedule for Hepatitis B (HBV) vaccination varies by age group, with infants receiving doses at birth, 1-2 months, and 6 months of age, while adults typically follow a 0,1, and 6-month schedule. 1

Infant Vaccination Schedule

  • All infants should receive their first dose of hepatitis B vaccine within 12 hours of birth, before hospital discharge 1

  • For infants born to HBsAg-negative mothers, the recommended schedule is: 1

    • First dose: Birth (before hospital discharge)
    • Second dose: 1-2 months of age
    • Third dose: 6 months of age
  • For infants born to HBsAg-positive mothers: 1

    • First dose: Within 12 hours of birth (along with HBIG)
    • Second dose: 1-2 months of age
    • Third dose: 6 months of age
    • Post-vaccination serologic testing at 9-12 months of age
  • For infants born to mothers with unknown HBsAg status: 1

    • First dose: Within 12 hours of birth
    • If mother tests positive: Add HBIG as soon as possible (within 7 days)
    • Complete series according to schedule based on mother's status
    • Final dose should not be administered before 24 weeks of age

Children and Adolescent Vaccination Schedule

  • Children and adolescents who were not vaccinated as infants should follow this schedule: 1
    • Ages 11-15 years: Either 3 doses at 0,1, and 6 months or an alternative 2-dose schedule of adult formulation (10 μg) at 0 and 4-6 months 1
    • Ages 11-19 years: 3 doses at 0,1, and 6 months 1

Adult Vaccination Schedule

  • For adults aged ≥18 years, multiple options are available: 1
    • Standard schedule: 3 doses at 0,1, and 6 months
    • Recombivax HB or Engerix-B: 20 μg per dose
    • Heplisav-B: 2 doses at 0 and 1 month (20 μg per dose)
    • PreHevbrio: 3 doses at 0,1, and 6 months (10 μg per dose)

Special Populations

  • Hemodialysis patients and other immunocompromised adults: 1, 2

    • Recombivax HB: 40 μg at 0,1, and 6 months
    • Engerix-B: 40 μg at 0,1,2, and 6 months
    • Annual anti-HBs testing recommended with booster doses when levels fall below 10 mIU/mL
  • Chronic kidney disease patients (pre-dialysis): 2

    • Recombivax HB: 10 μg at 0,1, and 6 months
    • Engerix-B: 20 μg at 0,1, and 6 months

Important Considerations

  • The minimum interval between the first and second doses is 4 weeks 1
  • The minimum interval between the second and third doses is 8 weeks 1
  • The minimum interval between the first and third doses is 16 weeks 1
  • The final dose in infants should not be administered before 24 weeks (164 days) of age 1
  • Vaccine doses administered ≤4 days before the minimum interval are considered valid 1

Alternative Schedules

  • An alternative schedule of 0,1,2, and 12 months may be used for certain populations 3
  • For children at low risk of immediate exposure, a schedule of 0,12, and 24 months has been shown to be highly immunogenic 4
  • Longer intervals between doses (especially between the second and third doses) result in higher final antibody levels 5

Post-Vaccination Testing

  • Post-vaccination serologic testing is recommended for: 1

    • Infants born to HBsAg-positive mothers
    • Healthcare personnel
    • Hemodialysis patients
    • HIV-infected persons
    • Other immunocompromised persons
  • Testing should be performed 1-2 months after completing the vaccination series 2

  • An anti-HBs level ≥10 mIU/mL indicates adequate protection 1, 2

Common Pitfalls to Avoid

  • Delaying the birth dose beyond 12 hours for infants born to HBsAg-positive mothers significantly increases risk of infection 1
  • Using standard adult doses instead of higher doses (40 μg) in dialysis patients results in inadequate immune response 2
  • Failing to check post-vaccination antibody titers in high-risk groups may leave patients unprotected 2
  • For preterm infants with birth weights <2000g, delaying vaccination until 1 month of age may improve seroprotection rates 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.